BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37595800)

  • 1. Re: '2020 list of human papillomavirus assays suitable for primary cervical cancer screening' by Arbyn et al.
    Giuffrè G; Iacobellis M
    Clin Microbiol Infect; 2023 Dec; 29(12):1606-1607. PubMed ID: 37595800
    [No Abstract]   [Full Text] [Related]  

  • 2. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Franco EL;
    Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
    [No Abstract]   [Full Text] [Related]  

  • 3. Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.
    Sawaya GF
    Ann Intern Med; 2008 Apr; 148(7):557-9. PubMed ID: 18378951
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cytology screening and management of abnormal cytology in adolescent girls.
    Kahn JA; Hillard PJ; ; ;
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):167-71. PubMed ID: 12804942
    [No Abstract]   [Full Text] [Related]  

  • 5. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Li T; Chen S; Li X; Wu Z; Zhao Y; Cui J; Liu B; Chen F; Zhang X; Qiao Y; Chen W
    Virol J; 2023 Jun; 20(1):116. PubMed ID: 37280665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus DNA testing in community screening for diseases of the cervix uteri.
    Chan SY
    Clin Sci (Lond); 1996 Sep; 91(3):250-2. PubMed ID: 8869401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Not Available].
    Bode-Lesniewska B; Caduff R
    Praxis (Bern 1994); 2017; 106(6):305-310. PubMed ID: 28300000
    [No Abstract]   [Full Text] [Related]  

  • 8. Human Papillomavirus DNA detection for cervical cancer screening.
    Press RD
    Mol Diagn; 2000 Sep; 5(3):245-7. PubMed ID: 11186127
    [No Abstract]   [Full Text] [Related]  

  • 9. Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes
    Regauer S; Reich O; Kashofer K
    Int J Gynecol Cancer; 2022 Apr; 32(4):581. PubMed ID: 35169071
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assurance in human papillomavirus testing for primary cervical screening.
    Cuschieri K; Fellner MD; Arroyo Mühr LS; Padalko E; Correa RM; Dillner J; Gultekin M; Picconi MA
    Int J Gynecol Cancer; 2023 May; 33(5):802-811. PubMed ID: 36914171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
    Nieves L; Enerson CL; Belinson S; Brainard J; Chiesa-Vottero A; Nagore N; Booth C; Pérez AG; Chávez-Avilés MN; Belinson J
    Int J Gynecol Cancer; 2013 Mar; 23(3):513-8. PubMed ID: 23334437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical screening: the evolving landscape.
    Davies-Oliveira JC; Round T; Crosbie EJ
    Br J Gen Pract; 2022 Aug; 72(721):364-365. PubMed ID: 35902262
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for cervical cancer.
    CA Cancer J Clin; 2020 Sep; 70(5):347-348. PubMed ID: 33460047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Precancerous lesions of the cervix and their treatment].
    Sobel G
    Magy Onkol; 2022 Dec; 66(4):280-287. PubMed ID: 36602247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 18. Could HPV testing become the sole primary cervical screening test?
    Sasieni P; Cuzick J
    J Med Screen; 2002; 9(2):49-51. PubMed ID: 12133918
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
    Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
    J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.